BNET Industries

Unigene Laboratories Inc.

(UGNE) is in the Pharma Industry

Market Cap:$92.3M
Last Fiscal Year Sales:$19.2M
  • Public
  • US
Dow Jones Description

We are a biopharmaceutical company engaged in the research, production and delivery of small proteins, referred to as peptides, for medical use. We have a patented manufacturing technology for producing many peptides cost-effectively. We also have patented oral and nasal delivery technologies that have been shown to deliver medically useful amounts of various peptides into the bloodstream. We currently have three operating locations: administrative and regulatory offices in Boonton, New Jersey, a laboratory research facility in Fairfield, New Jersey and a pharmaceutical production facility in Boonton, New Jersey. Our primary focus has been on the development of calcitonin and other peptide products for the treatment of osteoporosis and other indications. Our revenue for the past three years has primarily been derived from domestic sources. We have licensed in the U.S. our nasal calcitonin product for the treatment of osteoporosis, which we have trademarked as Fortical, to USL. Fortical was approved by the FDA in 2005. This is our first product approval in the United States. We have also licensed worldwide rights to our patented manufacturing technology for the production of calcitonin to Novartis. We have also licensed worldwide rights to our manufacturing and delivery technologies for oral PTH for the treatment of osteoporosis to GSK. ...

Number of Employees 103
Contact Information

81 Fulton St

Boonton, New Jersey 07005

unigene.com

(973) 265-1100

NAICS Code Medicinal and Botanical Manufacturing: 325411

Recent Events

  • Unigene Announces Financial Results for Third Quarter 2009

    11/09/09 - Financial Announcement - View Story

  • Unigene Licenses Osteo Drug to Tarsa

    10/21/09 - Licensing / Contract - View Story

News & Analysis

unigene laboratories inc. - All News and Analysis

advertisement
     UGNE $1.01 +0.03 (3.06% )
Intraday | 3 Month | 6 Month | 1 Year
Average Volume 163,451
Shares Outstanding 91.41M
Market Cap 92.3M
Year High 1.96
Year Low 0.37
Earnings Per Share -0.12
P/E Ratio -8.42
Dividend N/A
Yield N/A
IndustryTop Rated
advertisement
Click Here